Lobeline (Vietnamese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Lobeline" in Vietnamese language version.

refsWebsite

Global rank Vietnamese rank

28nih.gov

4^th place

7^th place

18doi.org

2^nd place

5archive.org

6^th place

4^th place

2drugs.com

399^th place

214^th place

2worldcat.org

5^th place

13^th place

1rightdiagnosis.com

low place

1ebi.ac.uk

5,849^th place

2,487^th place

archive.org

Marlow, S. P.; Stoller, J. K. (2003). “Smoking cessation”. Respiratory care. 48 (12): 1238–54, discussion 1254–6. PMID 14651764.
Eyerman, D. J.; Yamamoto, B. K. (2005). “Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum”. Journal of Pharmacology and Experimental Therapeutics. 312 (1): 160–9. doi:10.1124/jpet.104.072264. PMID 15331654.
Polston, J. E.; Cunningham, C. S.; Rodvelt, K. R.; Miller, D. K. (2006). “Lobeline augments and inhibits cocaine-induced hyperactivity in rats”. Life Sciences. 79 (10): 981–90. doi:10.1016/j.lfs.2006.05.006. PMID 16765386.
Wilhelm, C. J.; Johnson, R. A.; Lysko, P. G.; Eshleman, A. J.; Janowsky, A (2004). “Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system”. Journal of Pharmacology and Experimental Therapeutics. 310 (3): 1142–51. doi:10.1124/jpet.104.067314. PMID 15102929.
Miller, D. K.; Harrod, S. B.; Green, T. A.; Wong, M. Y.; Bardo, M. T.; Dwoskin, L. P. (2003). “Lobeline attenuates locomotor stimulation induced by repeated nicotine administration in rats”. Pharmacology Biochemistry and Behavior. 74 (2): 279–86. doi:10.1016/s0091-3057(02)00996-6. PMID 12479946.

doi.org

Stead LF, Hughes JR; Hughes (2012). “Lobeline for smoking cessation”. Cochrane Database Syst Rev. 2: CD000124. doi:10.1002/14651858.CD000124.pub2. PMID 22336780.
Buchhalter, A. R.; Fant, R. V.; Henningfield, J. E. (2008). “Novel pharmacological approaches for treating tobacco dependence and withdrawal: Current status”. Drugs. 68 (8): 1067–88. doi:10.2165/00003495-200868080-00005. PMID 18484799.
Neugebauer, N. M.; Harrod, S. B.; Stairs, D. J.; Crooks, P. A.; Dwoskin, L. P.; Bardo, M. T. (2007). “Lobelane decreases methamphetamine self-administration in rats”. European Journal of Pharmacology. 571 (1): 33–8. doi:10.1016/j.ejphar.2007.06.003. PMC 2104779. PMID 17612524.
Eyerman, D. J.; Yamamoto, B. K. (2005). “Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum”. Journal of Pharmacology and Experimental Therapeutics. 312 (1): 160–9. doi:10.1124/jpet.104.072264. PMID 15331654.
Polston, J. E.; Cunningham, C. S.; Rodvelt, K. R.; Miller, D. K. (2006). “Lobeline augments and inhibits cocaine-induced hyperactivity in rats”. Life Sciences. 79 (10): 981–90. doi:10.1016/j.lfs.2006.05.006. PMID 16765386.
Farook, J. M.; Lewis, B; Gaddis, J. G.; Littleton, J. M.; Barron, S (2009). “Lobeline, a nicotinic partial agonist attenuates alcohol consumption and preference in male C57BL/6J mice”. Physiology & Behavior. 97 (3–4): 503–6. doi:10.1016/j.physbeh.2009.02.031. PMID 19268674.
Zheng, G; Dwoskin, L. P.; Crooks, P. A. (2006). “Vesicular monoamine transporter 2: Role as a novel target for drug development”. The AAPS Journal. 8 (4): E682–92. doi:10.1208/aapsj080478. PMC 2751365. PMID 17233532.
Zheng, F; Zheng, G; Deaciuc, A. G.; Zhan, C. G.; Dwoskin, L. P.; Crooks, P. A. (2007). “Computational neural network analysis of the affinity of lobeline and tetrabenazine analogs for the vesicular monoamine transporter-2”. Bioorganic & Medicinal Chemistry. 15 (8): 2975–92. doi:10.1016/j.bmc.2007.02.013. PMC 2001191. PMID 17331733.
Zheng, G; Dwoskin, L. P.; Deaciuc, A. G.; Norrholm, S. D.; Crooks, P. A. (2005). “Defunctionalized lobeline analogues: Structure-activity of novel ligands for the vesicular monoamine transporter”. Journal of Medicinal Chemistry. 48 (17): 5551–60. doi:10.1021/jm0501228. PMC 3617589. PMID 16107155.
Wilhelm, C. J.; Johnson, R. A.; Eshleman, A. J.; Janowsky, A (2008). “Lobeline effects on tonic and methamphetamine-induced dopamine release”. Biochemical Pharmacology. 75 (6): 1411–5. doi:10.1016/j.bcp.2007.11.019. PMC 2435375. PMID 18191815.
Wilhelm, C. J.; Johnson, R. A.; Lysko, P. G.; Eshleman, A. J.; Janowsky, A (2004). “Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system”. Journal of Pharmacology and Experimental Therapeutics. 310 (3): 1142–51. doi:10.1124/jpet.104.067314. PMID 15102929.
Zheng, G; Horton, D. B.; Deaciuc, A. G.; Dwoskin, L. P.; Crooks, P. A. (2006). “Des-keto lobeline analogs with increased potency and selectivity at dopamine and serotonin transporters”. Bioorganic & Medicinal Chemistry Letters. 16 (19): 5018–21. doi:10.1016/j.bmcl.2006.07.070. PMC 3934794. PMID 16905316.
Miller, D. K.; Harrod, S. B.; Green, T. A.; Wong, M. Y.; Bardo, M. T.; Dwoskin, L. P. (2003). “Lobeline attenuates locomotor stimulation induced by repeated nicotine administration in rats”. Pharmacology Biochemistry and Behavior. 74 (2): 279–86. doi:10.1016/s0091-3057(02)00996-6. PMID 12479946.
PDB entry 2bys. Hansen, S. B.; Sulzenbacher, G; Huxford, T; Marchot, P; Taylor, P; Bourne, Y (2005). “Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations”. The EMBO Journal. 24 (20): 3635–46. doi:10.1038/sj.emboj.7600828. PMC 1276711. PMID 16193063.
Miller, D. K.; Lever, J. R.; Rodvelt, K. R.; Baskett, J. A.; Will, M. J.; Kracke, G. R. (2007). “Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists”. Drug and Alcohol Dependence. 89 (2–3): 282–91. doi:10.1016/j.drugalcdep.2007.02.003. PMID 17368966.
Ma, Yonggang; Wink, Michael (ngày 1 tháng 9 năm 2008). “Lobeline, a piperidine alkaloid from Lobelia can reverse P-gp dependent multidrug resistance in tumor cells”. Phytomedicine. 15 (9): 754–758. doi:10.1016/j.phymed.2007.11.028. ISSN 1618-095X. PMID 18222670.
Abdallah, Hossam M.; Al-Abd, Ahmed M.; El-Dine, Riham Salah; El-Halawany, Ali M. (ngày 8 tháng 10 năm 2016). “P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review”. Journal of Advanced Research. 6 (1): 45–62. doi:10.1016/j.jare.2014.11.008. ISSN 2090-1232. PMC 4293676. PMID 25685543.
J Pharmacol Exp Ther. 2004 Sep;310(3):1035-45. Epub 2004 Apr 30. DOI: 10.1124/jpet.104.068098

drugs.com

“Lobelia”. drugs.com.
“Lobelia”. drugs.com.

ebi.ac.uk

PDB entry 2bys. Hansen, S. B.; Sulzenbacher, G; Huxford, T; Marchot, P; Taylor, P; Bourne, Y (2005). “Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations”. The EMBO Journal. 24 (20): 3635–46. doi:10.1038/sj.emboj.7600828. PMC 1276711. PMID 16193063.

nih.gov

pubmed.ncbi.nlm.nih.gov

Stead LF, Hughes JR; Hughes (2012). “Lobeline for smoking cessation”. Cochrane Database Syst Rev. 2: CD000124. doi:10.1002/14651858.CD000124.pub2. PMID 22336780.
Marlow, S. P.; Stoller, J. K. (2003). “Smoking cessation”. Respiratory care. 48 (12): 1238–54, discussion 1254–6. PMID 14651764.
Buchhalter, A. R.; Fant, R. V.; Henningfield, J. E. (2008). “Novel pharmacological approaches for treating tobacco dependence and withdrawal: Current status”. Drugs. 68 (8): 1067–88. doi:10.2165/00003495-200868080-00005. PMID 18484799.
Neugebauer, N. M.; Harrod, S. B.; Stairs, D. J.; Crooks, P. A.; Dwoskin, L. P.; Bardo, M. T. (2007). “Lobelane decreases methamphetamine self-administration in rats”. European Journal of Pharmacology. 571 (1): 33–8. doi:10.1016/j.ejphar.2007.06.003. PMC 2104779. PMID 17612524.
Eyerman, D. J.; Yamamoto, B. K. (2005). “Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum”. Journal of Pharmacology and Experimental Therapeutics. 312 (1): 160–9. doi:10.1124/jpet.104.072264. PMID 15331654.
Polston, J. E.; Cunningham, C. S.; Rodvelt, K. R.; Miller, D. K. (2006). “Lobeline augments and inhibits cocaine-induced hyperactivity in rats”. Life Sciences. 79 (10): 981–90. doi:10.1016/j.lfs.2006.05.006. PMID 16765386.
Farook, J. M.; Lewis, B; Gaddis, J. G.; Littleton, J. M.; Barron, S (2009). “Lobeline, a nicotinic partial agonist attenuates alcohol consumption and preference in male C57BL/6J mice”. Physiology & Behavior. 97 (3–4): 503–6. doi:10.1016/j.physbeh.2009.02.031. PMID 19268674.
Zheng, G; Dwoskin, L. P.; Crooks, P. A. (2006). “Vesicular monoamine transporter 2: Role as a novel target for drug development”. The AAPS Journal. 8 (4): E682–92. doi:10.1208/aapsj080478. PMC 2751365. PMID 17233532.
Zheng, F; Zheng, G; Deaciuc, A. G.; Zhan, C. G.; Dwoskin, L. P.; Crooks, P. A. (2007). “Computational neural network analysis of the affinity of lobeline and tetrabenazine analogs for the vesicular monoamine transporter-2”. Bioorganic & Medicinal Chemistry. 15 (8): 2975–92. doi:10.1016/j.bmc.2007.02.013. PMC 2001191. PMID 17331733.
Zheng, G; Dwoskin, L. P.; Deaciuc, A. G.; Norrholm, S. D.; Crooks, P. A. (2005). “Defunctionalized lobeline analogues: Structure-activity of novel ligands for the vesicular monoamine transporter”. Journal of Medicinal Chemistry. 48 (17): 5551–60. doi:10.1021/jm0501228. PMC 3617589. PMID 16107155.
Wilhelm, C. J.; Johnson, R. A.; Eshleman, A. J.; Janowsky, A (2008). “Lobeline effects on tonic and methamphetamine-induced dopamine release”. Biochemical Pharmacology. 75 (6): 1411–5. doi:10.1016/j.bcp.2007.11.019. PMC 2435375. PMID 18191815.
Wilhelm, C. J.; Johnson, R. A.; Lysko, P. G.; Eshleman, A. J.; Janowsky, A (2004). “Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system”. Journal of Pharmacology and Experimental Therapeutics. 310 (3): 1142–51. doi:10.1124/jpet.104.067314. PMID 15102929.
Zheng, G; Horton, D. B.; Deaciuc, A. G.; Dwoskin, L. P.; Crooks, P. A. (2006). “Des-keto lobeline analogs with increased potency and selectivity at dopamine and serotonin transporters”. Bioorganic & Medicinal Chemistry Letters. 16 (19): 5018–21. doi:10.1016/j.bmcl.2006.07.070. PMC 3934794. PMID 16905316.
Damaj, M. I.; Patrick, G. S.; Creasy, K. R.; Martin, B. R. (1997). “Pharmacology of lobeline, a nicotinic receptor ligand”. The Journal of Pharmacology and Experimental Therapeutics. 282 (1): 410–9. PMID 9223582.
Miller, D. K.; Harrod, S. B.; Green, T. A.; Wong, M. Y.; Bardo, M. T.; Dwoskin, L. P. (2003). “Lobeline attenuates locomotor stimulation induced by repeated nicotine administration in rats”. Pharmacology Biochemistry and Behavior. 74 (2): 279–86. doi:10.1016/s0091-3057(02)00996-6. PMID 12479946.
PDB entry 2bys. Hansen, S. B.; Sulzenbacher, G; Huxford, T; Marchot, P; Taylor, P; Bourne, Y (2005). “Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations”. The EMBO Journal. 24 (20): 3635–46. doi:10.1038/sj.emboj.7600828. PMC 1276711. PMID 16193063.
Miller, D. K.; Lever, J. R.; Rodvelt, K. R.; Baskett, J. A.; Will, M. J.; Kracke, G. R. (2007). “Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists”. Drug and Alcohol Dependence. 89 (2–3): 282–91. doi:10.1016/j.drugalcdep.2007.02.003. PMID 17368966.
Ma, Yonggang; Wink, Michael (ngày 1 tháng 9 năm 2008). “Lobeline, a piperidine alkaloid from Lobelia can reverse P-gp dependent multidrug resistance in tumor cells”. Phytomedicine. 15 (9): 754–758. doi:10.1016/j.phymed.2007.11.028. ISSN 1618-095X. PMID 18222670.
Abdallah, Hossam M.; Al-Abd, Ahmed M.; El-Dine, Riham Salah; El-Halawany, Ali M. (ngày 8 tháng 10 năm 2016). “P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review”. Journal of Advanced Research. 6 (1): 45–62. doi:10.1016/j.jare.2014.11.008. ISSN 2090-1232. PMC 4293676. PMID 25685543.

ncbi.nlm.nih.gov

Neugebauer, N. M.; Harrod, S. B.; Stairs, D. J.; Crooks, P. A.; Dwoskin, L. P.; Bardo, M. T. (2007). “Lobelane decreases methamphetamine self-administration in rats”. European Journal of Pharmacology. 571 (1): 33–8. doi:10.1016/j.ejphar.2007.06.003. PMC 2104779. PMID 17612524.
Zheng, G; Dwoskin, L. P.; Crooks, P. A. (2006). “Vesicular monoamine transporter 2: Role as a novel target for drug development”. The AAPS Journal. 8 (4): E682–92. doi:10.1208/aapsj080478. PMC 2751365. PMID 17233532.
Zheng, F; Zheng, G; Deaciuc, A. G.; Zhan, C. G.; Dwoskin, L. P.; Crooks, P. A. (2007). “Computational neural network analysis of the affinity of lobeline and tetrabenazine analogs for the vesicular monoamine transporter-2”. Bioorganic & Medicinal Chemistry. 15 (8): 2975–92. doi:10.1016/j.bmc.2007.02.013. PMC 2001191. PMID 17331733.
Zheng, G; Dwoskin, L. P.; Deaciuc, A. G.; Norrholm, S. D.; Crooks, P. A. (2005). “Defunctionalized lobeline analogues: Structure-activity of novel ligands for the vesicular monoamine transporter”. Journal of Medicinal Chemistry. 48 (17): 5551–60. doi:10.1021/jm0501228. PMC 3617589. PMID 16107155.
Wilhelm, C. J.; Johnson, R. A.; Eshleman, A. J.; Janowsky, A (2008). “Lobeline effects on tonic and methamphetamine-induced dopamine release”. Biochemical Pharmacology. 75 (6): 1411–5. doi:10.1016/j.bcp.2007.11.019. PMC 2435375. PMID 18191815.
Zheng, G; Horton, D. B.; Deaciuc, A. G.; Dwoskin, L. P.; Crooks, P. A. (2006). “Des-keto lobeline analogs with increased potency and selectivity at dopamine and serotonin transporters”. Bioorganic & Medicinal Chemistry Letters. 16 (19): 5018–21. doi:10.1016/j.bmcl.2006.07.070. PMC 3934794. PMID 16905316.
PDB entry 2bys. Hansen, S. B.; Sulzenbacher, G; Huxford, T; Marchot, P; Taylor, P; Bourne, Y (2005). “Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations”. The EMBO Journal. 24 (20): 3635–46. doi:10.1038/sj.emboj.7600828. PMC 1276711. PMID 16193063.
Abdallah, Hossam M.; Al-Abd, Ahmed M.; El-Dine, Riham Salah; El-Halawany, Ali M. (ngày 8 tháng 10 năm 2016). “P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review”. Journal of Advanced Research. 6 (1): 45–62. doi:10.1016/j.jare.2014.11.008. ISSN 2090-1232. PMC 4293676. PMID 25685543.

pubchem.ncbi.nlm.nih.gov

National Center for Biotechnology Information. PubChem Database. (-)-Sedamine, CID=442657, https://pubchem.ncbi.nlm.nih.gov/compound/Sedamine (accessed on ngày 7 tháng 7 năm 2019)

rightdiagnosis.com

“Symptoms of Plant poisoning -- Lobeline”.

worldcat.org

Ma, Yonggang; Wink, Michael (ngày 1 tháng 9 năm 2008). “Lobeline, a piperidine alkaloid from Lobelia can reverse P-gp dependent multidrug resistance in tumor cells”. Phytomedicine. 15 (9): 754–758. doi:10.1016/j.phymed.2007.11.028. ISSN 1618-095X. PMID 18222670.
Abdallah, Hossam M.; Al-Abd, Ahmed M.; El-Dine, Riham Salah; El-Halawany, Ali M. (ngày 8 tháng 10 năm 2016). “P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review”. Journal of Advanced Research. 6 (1): 45–62. doi:10.1016/j.jare.2014.11.008. ISSN 2090-1232. PMC 4293676. PMID 25685543.